PureCycle Technologies, Inc.
NASDAQ:PCTIndustrial - Pollution & Treatment Controls
+$0.09 today
- Market cap
- $365.82M
- Beta
- 2.46
- P/E (TTM)
- -7.0
- EPS (TTM)
- -$1.25
Volume 10.78M
Average 5.26M
PCT Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
PureCycle Technologies, Inc.NASDAQ: PCT
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development growth accelerates
Q1 FY2026 research & development of $1.56M rose 0.9% year over year, ahead of the -3.4% change in trailing-twelve-month research & development. Sequentially, it fell 32.9% from the prior quarter. Over 3 fiscal years it compounded at +75.8% a year.
Context
- Research & development amounted to 70.9% of revenue in FY2025.
- Research & development increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +0.9% holds above the trailing-twelve-month pace of -3.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 5.93M USD
- Year-over-year change
- +75.4%
- 4-year CAGR
- +43.1%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.93M | +75.4% |
| FY2024 | 2024-12-31 | 3.38M | -48.9% |
| FY2023 | 2023-12-31 | 6.61M | +506.1% |
| FY2022 | 2022-12-31 | 1.09M | -22.7% |
| FY2021 | 2021-12-31 | 1.41M | — |
Research & Development vs competitors
How PCT compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -3.4% is the 2nd highest of 6, against a peer median of -32.2%.
- Research & development amounts to 54.5% of revenue for PCT, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | R$436M BRL | -9.9% | +6.4% | 0.7% | |
| LTM Jun 2026 | $267M USD | -50.9% | -28.9% | 3.2% | |
| LTM Sep 2026 | $140M USD | -1.4% | +3.6% | 0.4% | |
| LTM Sep 2026 | $20.2M USD | -32.2% | -2.1% | 1.8% | |
| LTM Mar 2026 | $5.94M USD | -3.4% | +75.8% | 54.5% | |
| LTM Sep 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding PCT) | — | -32.2% | +0.7% | 0.0% | |
Competitors are the stored peer set for PCT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 8.36M |
| Cost of Revenue | 10.55M | 26.56M | 18.86M | 34.71M | 142.98M |
| Gross Profit | (10.55M) | (26.56M) | (18.86M) | (34.71M) | (134.62M) |
| Gross Margin | — | — | — | — | -1611.3% |
| Research & Development | 1.41M | 1.09M | 6.61M | 3.38M | 5.93M |
| Selling, General & Admin | 57.62M | 76.97M | 107.29M | 138.95M | 59.48M |
| Operating Expenses | 59.03M | 54.76M | 95.04M | 110.67M | 31.74M |
| Depreciation & Amortization | 2.28M | 5.21M | 15.94M | 34.71M | 33.67M |
| EBITDA | (68.57M) | (79.54M) | (53.76M) | (197.66M) | (83.48M) |
| EBITDA Margin | — | — | — | — | -999.2% |
| Operating Income | (69.58M) | (81.32M) | (113.9M) | (145.38M) | (166.37M) |
| Operating Margin | — | — | — | — | -1991.2% |
| Interest Income | 6.65K | 4.95M | 3.76M | 5.19M | 5.86M |
| Interest Expense | 6.65M | 2.31M | 31.37M | 56.85M | 64.45M |
| Other Income / Expenses | (7.92M) | (3.43M) | 12.84M | (143.83M) | (15.23M) |
| Income Before Tax | (77.5M) | (84.75M) | (101.07M) | (289.22M) | (181.6M) |
| Pre-Tax Margin | — | — | — | — | -2173.5% |
| Income Tax Expense | 0 | 0 | 650K | (79K) | 970K |
| Net Income | (77.5M) | (84.75M) | (101.72M) | (289.14M) | (182.57M) |
| Net Margin | — | — | — | — | -2185.1% |
| EPS (Basic) | (0.75) | (0.54) | (0.62) | (1.82) | (1.08) |
| EPS (Diluted) | (0.75) | (0.54) | (0.62) | (1.76) | (1.21) |
| Weighted Avg Shares | 102.91M | 155.96M | 163.87M | 159.19M | 179.33M |
| Weighted Avg Shares (Diluted) | 102.91M | 155.96M | 164.01M | 164.11M | 180.45M |
PureCycle Technologies, Inc.
NASDAQ:PCT
Intrinsic Alpha fair value
Locked
Current Price
$1.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.